Back to Journals » OncoTargets and Therapy » Volume 16

Targeted Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Tafasitamab in Context

Total article views   HTML views PDF downloads Totals
4,701 Dovepress* 3,608+ 126 3,734
PubMed Central* 1,093 234 1,327
Totals 4,701 360 5,061
*Since 20 July 2023
Total mentioned Facebook Delicious Reddit Twitter Others
20 0 0 0 10 10

View citations on PubMed and Google Scholar